XML 36 R25.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Balance Sheet Details (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Schedule of Inventory | Inventory consisted of the following (in thousands):
|  | March 31, 2024 |  |  | December 31, 2023 |
Finished goods |  | $ | 7,576 |  |  | $ | 5,001 |
Work in process |  |  | 5,549 |  |  |  | 4,134 |
Raw material |  |  | 53,518 |  |  |  | 31,312 |
|  | $ | 66,643 |  |  | $ | 40,447 |
Reported as: |  |  |  |  |  |
Inventory |  | $ | 61,936 |  |  | $ | 35,819 |
Long-term inventory |  |  | 4,707 |  |  |  | 4,628 |
Total |  | $ | 66,643 |  |  | $ | 40,447 |
Schedule of Accrued Liabilities | Accrued liabilities consisted of the following (in thousands):
|  | March 31, 2024 |  |  | December 31, 2023 |
Accrued sales allowances |  | $ | 122,436 |  |  | $ | 90,718 |
Accrued contingent payments |  |  | 79,583 |  |  |  | 29,583 |
Accrued compensation and benefits |  |  | 26,061 |  |  |  | 42,718 |
Accrued research and development services |  |  | 23,878 |  |  |  | 32,883 |
Accrued consulting and professional fees |  |  | 19,684 |  |  |  | 18,804 |
Current portion of lease liabilities |  |  | 10,453 |  |  |  | 9,405 |
Current portion of accrued branded prescription drug fees |  |  | 7,836 |  |  |  | 718 |
Accrued royalties |  |  | 7,591 |  |  |  | 8,710 |
Other |  |  | 13,743 |  |  |  | 3,172 |
|  | $ | 311,265 |  |  | $ | 236,711 |

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accrued liabilities. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(c)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1 + Details
Name: | us-gaap_ScheduleOfInventoryCurrentTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration